KEATING LAURIE
SEC CIK 1620743 · EDGAR
BoughtSold
Most active insiders at IMRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Feinberg Peter | Dir | $225.7K | — |
| 2 | Schall Thomas J. | Dir | $101.1K | — |
| 3 | Hall Brett Matthew | CSO | $35.5K | — |
| 4 | Brakewood Harold Eugene | Chief Business Off | $25.0K | — |
| 5 | Neufeld Leah R | CHRO | $16.0K | — |
| 6 | Zeskind Benjamin J. | Pres AND CEO, Dir | $10.9K | — |
| 7 | Bookman Michael | CLO, Sec | $6,967 | — |
| 8 | Morales Mallory | CAO | $1,917 | — |
KEATING LAURIE made no open-market trades at IMRX in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-19 | 2022-05-06 | PEPG | PepGen Inc. | KEATING LAURIE | Dir | P - Purchase | $12.00 | +4,166 | 4,166 | New | +$50.0K | |
| 2022-05-17 | 2022-05-16 | IMRX | Immuneering Corp | KEATING LAURIE | Dir | P - Purchase | $5.00 | +7,000 | 14.0K | +100% | +$35.0K | |
| DM | 2021-08-09 | 2021-08-05 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | KEATING LAURIE | EVP, CLO | M - OptEx | $88.95 | +10.0K | 15.1K | +195% | +$889.5K |
| D | 2021-08-09 | 2021-08-05 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | KEATING LAURIE | EVP, CLO | S - Sale+OE | $188.95 | -10.0K | 5,132 | -66% | -$1.89M |
| 2021-08-04 | 2021-08-03 | IMRX | Immuneering Corp | KEATING LAURIE | Dir | P - Purchase | $15.00 | +7,000 | 7,000 | New | +$105.0K | |
| DM | 2021-07-14 | 2021-07-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | KEATING LAURIE | EVP, CLO | M - OptEx | $87.90 | +6,812 | 11.9K | +133% | +$598.8K |
| DM | 2021-07-14 | 2021-07-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | KEATING LAURIE | EVP, CLO | S - Sale+OE | $178.96 | -6,812 | 10.1K | -40% | -$1.22M |
Purchase Sale Sale after option exercise All abbreviations